Cite
HARVARD Citation
Trifan, A. et al. (2017). Efficacy and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with ribavirin for the treatment of HCV genotype 1b compensated cirrhosis in patients aged 70 years or older. Medicine. 96 (50), p. . [Online].